These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16516539)

  • 1. Interferon-alpha improves bone resorption and osteopenia in patients with chronic hepatitis C.
    Nishida N; Komatsu Y; Komeda T; Fukuda Y
    Hepatol Res; 2006 Apr; 34(4):222-7. PubMed ID: 16516539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection.
    Megahed A; Salem N; Fathy A; Barakat T; Alsayed MAEL; Mabood SAE; Zalata KR; Abdalla AF
    World J Pediatr; 2017 Aug; 13(4):346-352. PubMed ID: 28130750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN; Akçay G; BIlen H
    J Bone Miner Metab; 2004; 22(2):90-3. PubMed ID: 14999518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of urinary deoxypyridinoline crosslink/creatinine in rats after ovariectomy and anti-osteoporotic intervention].
    Hu YY; Xia WB; Liu HC; Meng XW; Zhou XY; Xing XP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):271-4. PubMed ID: 12905738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
    Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
    BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha.
    Voltchek I; Sologub T; Nowicky JW; Grigoryeva T; Belozyorova L; Belopolskaya M; Semenyako N; Lamanova E
    Drugs Exp Clin Res; 2000; 26(5-6):261-6. PubMed ID: 11345036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
    Hofmann WP; Kronenberger B; Bojunga J; Stamm B; Herrmann E; Bücker A; Mihm U; von Wagner M; Zeuzem S; Sarrazin C
    J Viral Hepat; 2008 Nov; 15(11):790-6. PubMed ID: 18673425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
    Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women].
    Fang TY; Liao EY; Wu XP; Liu SP; Xie H; Zhang H; Luo XH; Cao XZ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1607-9. PubMed ID: 15569454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
    Dill MT; Makowska Z; Duong FHT; Merkofer F; Filipowicz M; Baumert TF; Tornillo L; Terracciano L; Heim MH
    Gastroenterology; 2012 Sep; 143(3):777-786.e6. PubMed ID: 22677194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease.
    Meng XW; Chi BR; Chen LG; Zhang LL; Zhuang Y; Huang HY; Sun X
    World J Gastroenterol; 2005 Jul; 11(25):3962-5. PubMed ID: 15991303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
    Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study.
    Acharya SK; Sreenivas V; Gupta SD; Kumar S; Chawla YK; Tandon A; Habeeb A; Kar P; Chowdhury A; Choudhuri G; Sarin SK; Amarapurkar D; Arankalle V; Gupte MD; Gupta S; Mukherjee D; Seth D; Goyal R; Tandon BN
    J Clin Exp Hepatol; 2012 Mar; 2(1):10-8. PubMed ID: 25755401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the response to interferon-alpha.
    Begemann F; Jablonowski H
    J Clin Virol; 1999 Jun; 13(1-2):1-7. PubMed ID: 10405886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients.
    Bedimo R; Kang M; Tebas P; Overton ET; Hollabaugh K; McComsey G; Bhattacharya D; Evans C; Brown TT; Taiwo B
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):325-8. PubMed ID: 26499270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.
    Imanaka K; Tamura S; Fukui K; Ito N; Kiso S; Imai Y; Naka T; Kishimoto T; Kawata S; Shinomura Y;
    J Viral Hepat; 2005 Mar; 12(2):130-8. PubMed ID: 15720527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.